Search - tctmd.com

Displaying 61 - 80 of 1417

Sort: Relevancy | Date

Presentation TCT 2016

When and Which Antiplatelet Agent Should be Dropped When Using Oral Anticoagulant Therapy?

Presenter: David P. Faxon, C. Michael Gibson, Roxana Mehran

November 01, 2016

Presentation TCT 2016

Dosing Considerations of Oral Anticoagulant Therapy in the ACS and PCI Patient: Optimizing Efficacy While Minimizing Bleeding

Presenter: David P. Faxon, C. Michael Gibson

November 01, 2016

Presentation TCT 2016

General Overview and Highlights of the North American Consensus Document on Anticoagulation in the Atrial Fibrillation Patient With ACS or PCI

Presenter: David P. Faxon, C. Michael Gibson, Dominick J. Angiolillo

November 01, 2016

Presentation TCT 2016

Bioresorbable Scaffolds - Lessons Learned From the ABSORB Odyssey: Industry Perspectives

Presenter: Michael C. John, Gregg W. Stone, Chuck Simonton

November 01, 2016

Presentation TCT 2016

European Guidelines on Anticoagulation in the Atrial Fibrillation Patient With ACS or PCI

Presenter: David P. Faxon, C. Michael Gibson, Davide Capodanno

November 01, 2016

Presentation TCT 2016

FDA Perspectives on Short DAPT IDE Trials

Presenter: Michael C. John, Gregg W. Stone, Andrew Farb

November 01, 2016

Presentation TCT 2016

What Is Known (and What Is Not) About Discontinuing Aspirin or Clopidogrel in Patients on Chronic Oral Anticoagulants Plus DAPT

Presenter: David P. Faxon, C. Michael Gibson, Freek W.A. Verheugt

November 01, 2016

Presentation TCT 2016

The Big Picture: Incremental Bleeding Risks in Patients Requiring Chronic Oral Anticoagulants Plus DAPT

Presenter: David P. Faxon, C. Michael Gibson, Christopher B. Granger

November 01, 2016

Presentation TCT 2016

The Case for Surgery

Presenter: Michael A. Borger, Vinod H. Thourani, Martin Misfeld

November 01, 2016

News Daily News

Pfizer Discontinues Investigational PCSK9 Inhibitor Bococizumab

Michael O'Riordan

November 01, 2016

Presentation TCT 2016

Case #3 - Resolution: Did We Close It (?), and Long-term Patient Outcomes

Presenter: John D. Carroll, David E. Thaler, Michael J. Mullen

November 01, 2016

Presentation TCT 2016

The Case for Transcatheter Therapy

Presenter: Michael A. Borger, Vinod H. Thourani, Josep Rodés-Cabau

November 01, 2016

News Conference News TCT 2016

ReACT: Routine Angiographic Follow-up After PCI Does Not Lower Clinical Events

Michael O'Riordan

November 01, 2016

Presentation TCT 2016

The Case for a Trial of Medical Therapy

Presenter: John A. Bittl, David J. Maron, Michael E. Farkouh

November 01, 2016

Presentation TCT 2016

Debate - Should TAVR Be Offered to Every Patient With Aortic Stenosis? Yes, Even if Only to Avoid a Disfiguring Sternotomy!

Presenter: Andreas Baumbach, David Hildick-Smith, Michael J. Mullen

November 01, 2016

Presentation TCT 2016

Antiplatelet Therapy in Patients Who Need Anticoagulation: Current Guidelines, Ongoing Studies

Presenter: George D. Dangas, Debabrata Mukherjee, C. Michael Gibson

November 01, 2016

‘Promising’ SENTINEL Cerebral Protection in TAVR Collects Debris but Misses Primary Endpoint

News Conference News TCT 2016

Sentinel Cerebral Protection Device in TAVR ‘Promising’ but Trial Misses Primary Endpoint

Shelley Wood

November 01, 2016

Presentation TCT 2016

TCT 320: The Results of T-Provisional and Mini Crush Stenting in Patients with Bifurcation Lesions After Recanalization of Chronic coronary Arteries Occlusions. Comparative Analysis

Presenter: Michael A. Kutcher, Issam D. Moussa

November 01, 2016

Presentation TCT 2016

TCT 319: Side Branch Mortality Score for Prediction of Five Year Mortality After Provisional Side Branch Coronary Bifurcation Stenting A New Tool Based on Intracoronary Electrocardiogram (iECG) From iECG and Myonecrosis After Bifurcation Stenting

Presenter: Michael A. Kutcher, Issam D. Moussa

November 01, 2016

Presentation TCT 2016

TCT 318: Ten-year All-cause Mortality After Simple Versus Complex Stenting of Coronary Artery Bifurcation Lesions in the Randomized Nordic Bifurcation Study

Presenter: Michael A. Kutcher, Issam D. Moussa

November 01, 2016

Advertisement

When and Which Antiplatelet Agent Should be Dropped When Using Oral Anticoagulant Therapy?

Dosing Considerations of Oral Anticoagulant Therapy in the ACS and PCI Patient: Optimizing Efficacy While Minimizing Bleeding

General Overview and Highlights of the North American Consensus Document on Anticoagulation in the Atrial Fibrillation Patient With ACS or PCI

Bioresorbable Scaffolds - Lessons Learned From the ABSORB Odyssey: Industry Perspectives

European Guidelines on Anticoagulation in the Atrial Fibrillation Patient With ACS or PCI

FDA Perspectives on Short DAPT IDE Trials

What Is Known (and What Is Not) About Discontinuing Aspirin or Clopidogrel in Patients on Chronic Oral Anticoagulants Plus DAPT

The Big Picture: Incremental Bleeding Risks in Patients Requiring Chronic Oral Anticoagulants Plus DAPT

The Case for Surgery

Pfizer Discontinues Investigational PCSK9 Inhibitor Bococizumab

Case #3 - Resolution: Did We Close It (?), and Long-term Patient Outcomes

The Case for Transcatheter Therapy

ReACT: Routine Angiographic Follow-up After PCI Does Not Lower Clinical Events

The Case for a Trial of Medical Therapy

Debate - Should TAVR Be Offered to Every Patient With Aortic Stenosis? Yes, Even if Only to Avoid a Disfiguring Sternotomy!

Antiplatelet Therapy in Patients Who Need Anticoagulation: Current Guidelines, Ongoing Studies

Sentinel Cerebral Protection Device in TAVR ‘Promising’ but Trial Misses Primary Endpoint

TCT 320: The Results of T-Provisional and Mini Crush Stenting in Patients with Bifurcation Lesions After Recanalization of Chronic coronary Arteries Occlusions. Comparative Analysis

TCT 319: Side Branch Mortality Score for Prediction of Five Year Mortality After Provisional Side Branch Coronary Bifurcation Stenting A New Tool Based on Intracoronary Electrocardiogram (iECG) From iECG and Myonecrosis After Bifurcation Stenting

TCT 318: Ten-year All-cause Mortality After Simple Versus Complex Stenting of Coronary Artery Bifurcation Lesions in the Randomized Nordic Bifurcation Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content